Hypomelanotic macules in tuberous sclerosis

D. J. Ruiter(Radboud University Nijmegen), E. Scheffer, Sjoerd G. van Duinen(Leiden University Medical Center), W.A. van Vloten(Leiden University), A. C. B. Peters(Leiden University Medical Center), B.J. Mauw(Leiden University Medical Center), N.J. Dijkshoorn(Leiden University Medical Center)

Archives of Dermatological Research

September 1, 1981

10.1007/bf00412544

Cited by 3

Related Papers

N-ras mutations in human cutaneous melanoma from sun-exposed body sites.

|Molecular and Cellular Biology|1989|280

Aneurysmal bone cysts.A clinicopathological study of 105 cases

|Cancer|1977|269

c‐myc down‐regulates class I HLA expression in human melanomas.

|The EMBO Journal|1988|257

Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.

|Journal of Clinical Oncology|1998|246

Final results of the EORTC 18871/DKG 80-1 randomised phase III trial

|European Journal of Cancer|2003|240